Discounts provided by drugmakers to middlemen appear to be driving up list prices of prescription medicines and ultimately some consumer costs, a new report by a team of researchers at the University of Southern California said.
Discounts provided by drugmakers to middlemen appear to be driving up list prices of prescription medicines and ultimately some consumer costs, a new report by a team of researchers at the University of Southern California said.